Posts tagged “Biotech & Life Science”

January 30, 2007

Premium Lock Metabolon Adds Three Members to Management Team

Metabolon Drug discovery firm adds sales, strategic developing, and marketing executives.

January 30, 2007

Premium Lock CeNeRx Prepares To Launch First Clinical Trial for Lead Drug

CeNeRx RTP startup receives FDA approval for testing of Tyrima, which targets depression, anxiety.

January 30, 2007

Premium Lock Alphavax Targets Influenza, Global Threat of CMV in New Clinical Trials

Alphavax FDA grants approval for test of potential vaccine targeting CMV, a virus that infects up to 80% of U.S. adults age 40 and older and also causes thousands of birth defects. A pandemic vaccine also will be tested.

January 29, 2007

Premium Lock Diosynth Biotechnology Names New President

Diosynth RTP-based contract manufacturing firm is being merged with Organon Biosciences.

January 25, 2007

Premium Lock RTP-Based Pharmaceutical Firm Launches Osteoarthritis Drug

Zylera Zylera’s Relamine targets joint swelling, pain associated with most common form of arthritis.

January 25, 2007

Premium Lock Genomics Firm Gentris Receives FDA Approval for Test Product

Genomic testing Federal approval of GentriSure covers liver enzyme that metabolizes most prescribed drugs. Gentris also receives FDA approval for its production facility.

Updated January 24, 2007

Premium Lock RTI, Duke, UNC Asheville to Study Chernobyl Radiation Impact

RTI The U.S. Department of Energy is putting $5M into project that will seek to develop radiation diagnostics, treatments.

Updated January 23, 2007

Premium Lock N.C. Biotech Center CEO To Leave March 31

Leslie Alexandre joined Biotech Center in 2002. Leslie Alexandre, who led an aggressive program to expand state's life science industry, plans to pursue other opportunities. 'I give her a lot of credit as a change agent in a positive way,' CED's Monica Doss says.

January 22, 2007

Premium Lock Chelsea Therapeutics Receives 'Orphan' Status for Drug Candidate

FDA approval FDA decision could mean seven years of exclusivity for Droxidopa, a treatment targeting neurogenic disorder.

Updated January 19, 2007

Premium Lock FDA Grants Approval for Optical Imaging Device from Duke Spin-out

Bioptigen Bioptigen can begin marketing its non-invasive scanner for eye disease research. Company also receives two federal research grants

Updated January 19, 2007

Premium Lock GSK to Compare Cancer Vaccine with Merck Product

GSK Drug maker is seeking FDA approval for vaccine to combat cervical cancer.

Updated January 18, 2007

Premium Lock Government Awards GSK, Novartis Huge Contracts for Immune System Booster

GSK to receive $63.3M, Novartis $54.8M to produce adjuvant, a product designed to increase effectiveness of influenza drugs. Novartis will utilize Holly Springs plant for project.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith